Overview

Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a small dose of glucagon (mini-dose glucagon) is effective for the treatment of non-severe hypoglycemia in adults with type 1 diabetes (T1D).
Phase:
Phase 2
Details
Lead Sponsor:
Jaeb Center for Health Research
Collaborator:
Xeris Pharmaceuticals
Treatments:
Glucagon
Glucagon-Like Peptide 1